DEC 24, 2019 6:20 PM PST

The effect of aspirin on breast cancer

New research published recently in the journal Cancer aims to better understand the effects that aspirin can have on breast cancer. Previous research has suggested that aspirin can reduce the risk of breast cancer by up to 20% and that it also has the potential to aid in treatment for existing cancers. This most recent study looked specifically at the anti-inflammatory effects that aspirin has on women who have already received treatment for breast cancer.

What role can aspirin play for women with breast cancer? Photo: Pixabay

The research comes from scientists at the University of North Carolina (UNC) at Chapel Hill's Gillings School of Global Public Health. The study focuses on aspirin, which is a common nonsteroidal anti-inflammatory drug (NSAID), because of its previously determined health benefits, such as preventing blood clots and reducing inflammation. The researchers wanted to further extend the understanding of aspirin’s health benefits towards breast cancer.

"Chronic inflammation is a key player in the development of multiple cancer types, including breast cancer," notes the recent study's first author, Tengteng Wang, Ph.D. Tengteng and colleagues go on to explain in the study that their research was guided by the fact that "the underlying biological mechanisms and epidemiological findings on aspirin use in relation to prognosis and mortality after [breast cancer] are limited and inconsistent."

In conducting the investigation, the researchers analyzed data from 1,266 women with breast cancer from the Long Island Breast Cancer Study. They specifically wanted to see if aspirin use would have any influence on DNA methylation in 13 genes related to breast cancer. The genes they focused on were APC, BRCA1, CDH1, CYCLIND2, DAPK1, ESR1, GSTP1, HIN, CDKN2A, PR, RAR-beta, RASSF1A, and TWIST1.

The study’s findings conclude a link between the methylation of certain genes and aspirin use. As explained by Medical News Today, the study showed that “women who had taken aspirin at least once per week for 6 weeks before receiving their breast cancer diagnosis and showed methylation in BRCA1 — a gene that promotes breast cancer tumors — saw an increase of 67% in all-cause mortality following treatment.” Meanwhile, “Women who had unmethylated BRCA1 and PR genes and who had taken aspirin in the period before their diagnosis saw a decrease in cancer-related mortality of 22–40%.”

The researchers admit that their study is just the beginning of fully comprehending the effects of aspirin on breast cancer. Tengteng Wang and Professor Marilie Gammon commented: "Future research designed to replicate our findings should include a larger sample size to allow examination of patterns of aspirin use, and an enlarged panel of genes to explore the role of genetic predisposition in driving overall genetic instability on survival after a breast cancer diagnosis.”

Sources: Cancer, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 20, 2019
Clinical & Molecular DX
NOV 20, 2019
New diagnostic technology seeks out cancer DNA in blood
For many cancers, early detection has a tremendous impact on patient outcomes. Yet, sadly, many of the most common malignancies, like those of the stomach,...
DEC 04, 2019
Cancer
DEC 04, 2019
Photon up-conversion for new cancer treatments
Scientists from the University of California, Riverside and The University of Texas at Austin have made a breakthrough in materials science that has signif...
DEC 14, 2019
Cancer
DEC 14, 2019
Common antibiotic could improve radiation therapy
Have you ever taken the antibiotic vancomycin? As a commonly prescribed antibiotic for colitis and infections caused by Clostridium difficile, vancomycin i...
DEC 21, 2019
Cancer
DEC 21, 2019
Processed meats containing nitrites linked to cancer
Since 2015, when the World Health Organization (WHO) classified processed meats as Group 1 carcinogens, science has supported the idea that these foods pos...
FEB 08, 2020
Cancer
FEB 08, 2020
Magic mushrooms help cancer patients' depression
A follow-up to a study originally published in the Journal of Psychopharmacology in 2016 reports the long-term benefits of a one-time, single-dose tre...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diag...
Loading Comments...